Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain
Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the analgesic efficacy of Egalet-002 twice daily
(BID) in patients with moderate-to-severe chronic low back pain